Chapter 1: Pharmacokinetics and Pharmacodynamics Flashcards
Pharmacokinetics vs Pharmacodynamics
Pharmacokinetics- how substances are distributed through the body
Pharmacodynamics- interactions of the substance with a receptor
Pharmacology
the scientific study of actions of drugs and their effects on a living organism
Neuropharmacology
Psychopharmacology
Neuropsychopharmacology
Neuropharmacology- drug induced changes in nervous system function
Psychopharmacology- drug-induced changes in mood, thinking, and behavior
Neuropsychopharmacology- drug- induced changes in the nervous system that influence behavior
Drug Action
- specific molecular change
- drug binds to its target (receptor)
- can be very distant from ultimate effect
- occur at many different target sites
Drug Effect
- more widespread/ systemic change
- eg. in physiology or behavior
- Therapeutic effects
- desirable effects of a drug - Side effects
- undesirable: annoying, distressing, dangerous
Specific Drug Effects vs Nonspecific Drug Effects
Specific Drug Effects
- result from interactions between a drug and it’s target (pharmacodynamics)
Nonspecific Drug Effects
- may affect outcome of drug use - can't be explained by drug-receptor interactions - include mood, expectations, perceptions, attitudes - ex. different moods when drunk, placebo effect
Pharmacokinetics
- what body does to drug
- mechanisms involved in delivering a drug to its target, where it can have a pharmacological effect
- Administration- routes of administration
- Absorption and Distribution- pass through variety of cell membranes and enter blood plasma
- Elimination
- Metabolism- inactivation
- Excretion- liver metabolites are excreted/ unaltered forms are excreted
Bioavailability- […]
depends on several factors:
- (...) into the blood by route of administration - affected by (...) - drug (...) to target sites - (...) - (...)/ clearance mechanisms - for a drug to be (...) it must be (...) or (...)
Bioavailability- is the amount of drug in the blood that is free to act on a specific target
depends on several factors:
- absorption into the blood by route of administration - affected by lipid solubility, ionization, selective barriers - drug distribution to target sites - plasma proteins, depot binding (inactive storage site) - elimination/ clearance mechanisms - for a drug to be bioactive it must be unchanged (not metabolized) or active metabolite
Pharmacokinetic factors determine bioavailability
- Drug Administration- oral, intravenous, intraperitoneal, subcutaneous, intramuscular, inhalation
- Absorption and Distribution- membranes of oral cavity, gastrointestinal tract, peritoneum, skin, muscles, lungs
- Binding
- Target site: neuron receptor
- inactive storage depots: bone and fat - Inactivation- liver, stomach, intestine, kidney, blood plasma, brain
- Excretion- intestines, kidneys, lungs, sweat glands
Excretion products: feces, urine, water vapor, sweat, saliva
Time Course of Plasma Concentration
*picture on phone
Absorption
movement of the drug from site of administration to the blood circulation
- oral delivery requires absorption through the GI tract - drugs must survive this "first-pass" metabolism (toxins go through portal vein to liver where they're altered by enzymes before passing through heart for circulation) in active form - once in the blood, a drug can reach its active site or bind to inactive sites in blood (eg albumin) muscle or fat
4 common routes of administration
Oral injection: tablet, capsule, liquid
Injection: intramuscular, intravenous, subcutaneous
- may not go through first pass metabolism
Inhalation: smoking, inhalers, nebulizers
Through mucous membranes: sublingual, intranasal, rectal suppository, transdermal
Route of administration affects drug half-life and bioavailability
Absorption: lipid solubility
- cell membranes are comprised of phospholipid bilayers
- substances must be lipid-soluble to pass through the membranes by passive diffusion
- movement down a concentration gradient
- higher concentration gradient= faster movement
Membrane lipid bilayer:
- Phosphate head group - carry ionic charge - polar, hydrophilic - 2 fatty acid tails - do not carry charge - non-polar, hydrophobic - impedes ability of substances to cross membrane
Absorption: ionization
- most psychoactive drugs are weak acids or weak bases that are ionized in water
- passive diffusion ceases when drug is 50% ionized and 50% unionized
- highly charged molecules don’t absorb easily in GI tract - ionization depends on pH of solution and pKa of molecule
- example. aspirin
Absorption: transport across membranes
- Blood- Brain Barrier: supplies O2, glucose, AA; gets rid of CO2, and other waste
- reduces diffusion of ionized molecules - Placental Barrier
- acute toxicity
- teratogenic effects (some depend on timing of exposure)
Distribution
once absorbed, a drug is distributed throughout the body via the circulatory system
The amount of drug at a target is a fraction of the total dose administered
Drug depots
- aka silent receptors - plasma proteins ( eg albumin), muscle and fat - affects its administration and elimination - reduces bioavailability - determines the duration and intensity of the drug effect; including side-effects - non- selective binding; drug displacement
Depot binding
- binding of drugs to inactive sites - delays onset, lowers intensity (once a month injection rather than daily dose) - contributes to drug interactions due to non- selective binding/ drug displacement - slows metabolism, prolongs duration - can terminate drug action - reduces drug concentration at active sites so only free, unbound drugs can pass through membrane
Elimination
process by which the body removes drug
Psychoactive drugs are commonly metabolized […] and excreted by the […]
Psychoactive drugs are commonly metabolized liver and excreted by the kidney
- rates of elimination depend on drug concentration in the blood, and on the blood flow into the metabolizing organ
- First-order kinetics- exponentially cleared from body; unsaturated enzymes
- Half- life (t1/2)- amount of time to clear 50% of drug (most drugs of clearance of 6 half-lifes)
- determines steady state plasma levels- desired blood concentration of drug when absorption/ distribution= metabolism/ excretion - clearance rate is an important factor when considering dosing schedule (time interval between doses)
- Some drugs are cleared on zero-order kinetics- drug cleared at constant rate regardless of concentration; enzyme saturation (ex ethyl alcohol)
Extended Release
lower peak concentration, but much longer duration
The liver […] the drug
The liver inactivates the drug
- The active substance is converted to an inactive substance (metabolite) by
- microsomal liver enzymes (CYP450 family) that chemically modify the drug
2 types of modifications: makes molecules more soluble
- type 1 (nonsynthetic, nonconjugate): oxidation (most common), reduction, hydrolysis - type 2 (synthetic, conjugate): glucuronide, sulfate, methyl groups
type 2 modifications cause molecules become bulkier
The kidney […] the drug
The kidney excrete the drug
- The kidneys filter the metabolites from blood, to be excreted in urine
- has an easier time getting bulkier, more soluble molecules out
Drug elimination is affected by the amount and activity of liver enzymes
Enzyme Inhibition- some drugs directly inhibit liver enzymes
- metabolism decreases - drug levels go up
Enzyme Induction- increased enzyme levels following chronic use
- can affect other drugs modified by some enzyme
Drug Competition occurs when drugs share metabolic system
Patient- related factors affecting drug elimination
Genetics
Gender
Age
Liver disease